ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AOR Aortech International Plc

126.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 126.50 123.00 130.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Aortech Share Discussion Threads

Showing 2701 to 2722 of 8900 messages
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
07/1/2013
11:35
not looking good
papillon88
05/1/2013
10:18
Harrogate, interesting points.... My understanding is that our largest shareholder with almost 20% of the company, Active Capital (previously chaired by our erstwhile Chairman and possible saviour, Bill Brown!), is suspended pending an immediate winding up of the company and disposal of its remaining assets.....so there's (at least) 20% of the business which is seeking an immediate buyer (at the right price)....so I don't see how this stacks up with continuing the company's interest with a JV....at least not unless there is some sort of reasonable buy-out offer to existing shareholders.... In any case, did we not already announce the way forward was to sell the company? If that strategy has changed then Bill and the board need to tell us PDQ.
bearfoot
05/1/2013
08:57
I just wonder how this will work in a practical sense. If we sell the polymer business for say £1.40 a share ( £8m after dilution ) how will we get this money ..it will have to be paid by way of a dividednd and so subject to income tax which would be a pain give the capital loss on the shares. If we then end up in a JV on the heart valve that could take years to come to commercial reality how do we get value out or are we destined to stay in AOR for years to see if it all works ( Sounds familiar). We are clearly better off than we were and it is great that we stuck it to StJ but I am not sure we are as shareholders in as good a spot as we think in terms of a nice clean 3/4 month resolution. Any thoughts?
harrogate
04/1/2013
11:45
Piccolino3- I think we may find that some sort of JV will take place on the Heart Valve.
gac141
03/1/2013
21:19
Just a word of caution re the heart valve. It is a little surprising that St J being a major player in that market would not have taken an option on the percutaneous opportunity. Secondly, few major players would jump without some clinical data, and that takes millions to obtain
piccolino3
03/1/2013
17:32
Keep selling if you wish but that may be a mistake.
1prophet
03/1/2013
13:33
sellers below the bid price now :-(
papillon88
03/1/2013
09:55
Papillon- 5000 buy and 1000 sell.. Seen it a lot worse than that...
gac141
03/1/2013
09:35
The stock is difficult to sell and very easily offered which suggests a further fall in the share price
papillon88
02/1/2013
15:58
1Prophet: Every chance if the Heart Valve is as good as others and Company are saying.
way2000
02/1/2013
13:04
So AOR are positioned. Could shareholders get their £3.75 back? I think so.
1prophet
02/1/2013
12:06
Yes..Happy New Year.
tadders2
02/1/2013
11:25
Could be a happy and sucessful early start to the New Year. Broker says he has heard that there are several V.interested suitors.
way2000
02/1/2013
09:31
We all second that !!! Happy New Year
harrogate
02/1/2013
09:30
Happy New year to all holders here. It has been a very rocky road but phase 1 of 3 is complete. I have confidence that the focused Management will conclude the two deals needed to make 2013 a good year for us. My hope and expectation would be for this to be wrapped up in 4 months.
gac141
30/12/2012
15:13
Very funny harrogate the best laugh of the day.

For me I was always for the heart valve and if we haven't fallen behind the game I don't see why it shouldn't be a very valuable asset. With the right partner who knows, but the transcatheter percutaneous heart valve is a very exciting place to be in.

Good luck to Bill and Eddie I really thank and commend them for the extreme effort they have made over this crisis period. Also, I am very grateful we have come out of this with plenty of skin in the game. Peter

1400
30/12/2012
15:02
Clearly focusing on the wives rather than his paid day job. He has been a failure on biblical proportions.
way2000
30/12/2012
12:50
If he lives in Utah he might have a few wives to look after and so need the money.
harrogate
30/12/2012
09:27
Are we really based in Utah?
harrogate
30/12/2012
09:23
Medical materials maker confident of finding buyer for polymer unit

By PETER RANSCOMBE
Published on Friday 28 December 2012 00:00


AORTECH, the former Glasgow life sciences firm now based in Utah, will hold talks in the New Year to sell its medical polymers business.


The Aim-quoted business, which produces plastics used to make medical devices, put the unit on sale earlier this year but failed to find a buyer due to its "dwindling cash position".

After settling a legal dispute with big customer St Jude Medical on Christmas Eve, AorTech believes it is now in a much-stronger position to find a buyer because the threat of a potential "fire sale" has been removed.

Under the deal, AorTech will receive $3.9 million (£2.4m), with $3.4m due now and a further $500,000 on 31 March. St Jude will also buy AorTech's factory for $250,000.

Chairman Bill Brown said the company will now look for a partner to develop its plastic heart valve technology, which has taken a back seat over the past year.

Brown, a former Edinburgh-based F&C fund manager, added: "We have succeeded in stabilising the company, we have a decent cash position and our contracts are now valuable.

"We will seek to take the company forward with a view to creating value for shareholders. This is likely to result in a double strategy of seeking a sale of the polymer business and a deal on the heart valve technology."

His comments came as the firm posted a pre-tax loss of $1.5m for the six months to 30 September, compared with a profit of $250,000 a year earlier.

AorTech was founded in 1992 but closed its Bellshill plant in 2004 and moved first to Australia and then to the United States.

gac141
28/12/2012
14:30
Great result for AOR. Back in the game. Watch this get acquired early 2013!
1prophet
28/12/2012
11:49
I am suspicious of those who knock Brown & Mcdaid, the very folk who saved the company. I sold out because I distrusted the US judiciary system, but I still admire the courage of those who but their money at serious risk to save the company. I thought the chances of success in the courts was much less than 50% but Brown & Mcdaid called St Judes bluff, and it worked, otherwise St J would have let the legal proceedings continue.
bowmans
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock